Sequential therapy with cyclosporine and adalimumab in patients with severe plaque psoriasis: a series of five cases

被引：0
|
作者：
Gattu, S. [1 ,2 ]
Wu, J. J. [3 ]
Koo, J. Y. [2 ]
机构：
[1] Univ Calif Irvine, Irvine, CA USA
[2] Univ Calif San Francisco, San Francisco, CA 94143 USA
[3] Kaiser Permanente Med Ctr, Los Angeles, CA 90034 USA
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2009年 / 129卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
275
引用
收藏
页码：S46 / S46
页数：1
相关论文
共 50 条
  • [41] Methotrexate therapy in 10 children with severe plaque psoriasis
    Cokin, B.
    Ogboli, M.
    Moss, C.
    BRITISH JOURNAL OF DERMATOLOGY, 2006, 155 : 33 - 33
  • [42] Effects of adalimumab on health status as measured by EQ-5D in patients with moderate to severe plaque psoriasis
    Wallace, K
    Bissonnette, R
    Leonardi, C
    Chen, D
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2005, 52 (03) : P181 - P181
  • [43] Patient-reported outcomes with etanercept therapy in patients with plaque psoriasis who lost response to adalimumab
    Papp, Kim A.
    Tyring, Stephen
    Stolshek, Bradley S.
    Rice, Kara Creamer
    Collier, David H.
    Kricorian, Greg
    Iles, Jan
    Kaliyaperumal, Arunan
    Bagel, Jerry
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017, 76 (06) : AB191 - AB191
  • [44] Treatment of plaque psoriasis by sequential therapy with two 'biologics': the 'hit and run' approach, a report of two cases
    Barde, C
    Thielen, AM
    Kuenzli, S
    Saurat, JH
    BRITISH JOURNAL OF DERMATOLOGY, 2006, 155 (01) : 211 - 213
  • [45] Adalimumab for moderate to severe chronic plaque psoriasis: efficacy and safety of retreatment and disease recurrence following withdrawal from therapy
    Papp, K.
    Crowley, J.
    Ortonne, J. -P.
    Leu, J.
    Okun, M.
    Gupta, S. R.
    Gu, Y.
    Langley, R. G.
    BRITISH JOURNAL OF DERMATOLOGY, 2011, 164 (02) : 434 - 441
  • [46] Sequential use of biologics in the treatment of moderate-to-severe plaque psoriasis
    Leman, J.
    Burden, A. D.
    BRITISH JOURNAL OF DERMATOLOGY, 2012, 167 : 12 - 20
  • [47] Effects of adalimumab and secukinumab on comorbidities associated with metabolism in patients with plaque psoriasis
    Zhang, Si
    Cai, Lin
    Zhang, Heng
    Zhao, Zheng
    Liu, Xiaoyang
    Zhao, Yan
    Zhang, Jianzhong
    CHINESE MEDICAL JOURNAL, 2022, 135 (18) : 2248 - 2250
  • [48] Effects of adalimumab and secukinumab on comorbidities associated with metabolism in patients with plaque psoriasis
    Zhang Si
    Cai Lin
    Zhang Heng
    Zhao Zheng
    Liu Xiaoyang
    Zhao Yan
    Zhang Jianzhong
    中华医学杂志(英文版), 2022, 135 (18)
  • [49] Efficacy and Safety Similarity of Biosimilar Adalimumab-aqvh to Adalimumab in Patients with Moderate-to-Severe Chronic Plaque Psoriasis: A Phase III Study
    Finck, Barbara
    Tang, Helen
    Jensen, Kathy
    Civoli, Francesca
    Tatarewicz, Suzanna
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 3620 - 3621
  • [50] Risankizumab vs. adalimumab for moderate-to-severe plaque psoriasis: a critical appraisal
    Al-Janabi, A.
    Warren, R. B.
    BRITISH JOURNAL OF DERMATOLOGY, 2020, 183 (02) : 220 - 221
12345